Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency. [electronic resource]
- Rheumatology (Oxford, England) Oct 2012
- 1855-9 p. digital
Publication Type: Journal Article
1462-0332
10.1093/rheumatology/kes097 doi
Adolescent Adult Antibodies, Monoclonal--therapeutic use Antibodies, Monoclonal, Humanized Child Child, Preschool Female Humans Immunologic Factors--therapeutic use Interleukin 1 Receptor Antagonist Protein--therapeutic use Interleukin-1beta--antagonists & inhibitors Male Mevalonate Kinase Deficiency--drug therapy Treatment Outcome